Dr. John Fezza, MD

NPI: 1184715187
Total Payments
$3.4M
2024 Payments
$586,458
Companies
18
Transactions
3,220
Medicare Patients
4,154
Medicare Billing
$795,161

Payment Breakdown by Category

Other$1.9M (55.2%)
Consulting$979,222 (28.6%)
Travel$339,149 (9.9%)
Royalty/License$130,000 (3.8%)
Food & Beverage$62,531 (1.8%)
Research$23,475 (0.7%)
Education$42.25 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1.9M 324 55.2%
Consulting Fee $979,222 171 28.6%
Travel and Lodging $339,149 1,388 9.9%
Royalty or License $130,000 4 3.8%
Food and Beverage $62,531 1,315 1.8%
Unspecified $23,475 13 0.7%
Education $42.25 5 0.0%

Payments by Type

General
$3.4M
3,207 transactions
Research
$23,475
2 transactions
Ownership
$0
11 transactions

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $2.0M 2,337 $0 (2022)
ABBVIE INC. $1.3M 740 $0 (2024)
Visant Medical, Inc. $130,000 9 $0 (2022)
MERZ NORTH AMERICA, INC. $29,859 43 $0 (2024)
Galderma Laboratories, L.P. $20,682 54 $0 (2021)
Nordic Pharma, Inc. $4,999 1 $0 (2024)
Merz Pharmaceuticals GmbH $1,793 20 $0 (2017)
SUN PHARMACEUTICAL INDUSTRIES INC. $125.00 1 $0 (2021)
Horizon Therapeutics plc $119.06 1 $0 (2021)
Valeant Pharmaceuticals North America LLC $108.38 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $586,458 321 ABBVIE INC. ($581,182)
2023 $644,135 410 ABBVIE INC. ($635,441)
2022 $652,593 527 Allergan, Inc. ($564,466)
2021 $569,356 637 Allergan, Inc. ($555,293)
2020 $202,366 237 Allergan, Inc. ($192,345)
2019 $364,489 603 Allergan Inc. ($360,233)
2018 $296,713 265 Allergan Inc. ($179,219)
2017 $109,322 220 Allergan Inc. ($107,007)

All Payment Transactions

3,220 individual payment records from CMS Open Payments — Page 1 of 129

Date Company Product Nature Form Amount Type
12/31/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $957.00 General
12/30/2024 Nordic Pharma, Inc. Lacrifill (Device) Consulting Fee Cash or cash equivalent $4,999.02 General
Category: Opthalmics
12/24/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,196.25 General
12/24/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,010.17 General
12/17/2024 ABBVIE INC. BOTOX (Biological) Consulting Fee Cash or cash equivalent $1,595.00 General
Category: FACIAL AESTHETICS
12/17/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $744.33 General
12/10/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $2,153.25 General
12/10/2024 ABBVIE INC. BOTOX (Biological) Travel and Lodging In-kind items and services $20.00 General
Category: FACIAL AESTHETICS
12/03/2024 ABBVIE INC. BOTOX (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $31,900.00 General
Category: FACIAL AESTHETICS
12/03/2024 ABBVIE INC. BOTOX (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $17,500.00 General
Category: FACIAL AESTHETICS
12/03/2024 ABBVIE INC. BOTOX (Biological) Consulting Fee Cash or cash equivalent $1,595.00 General
Category: FACIAL AESTHETICS
11/26/2024 ABBVIE INC. BOTOX (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $17,500.00 General
Category: FACIAL AESTHETICS
11/26/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $1,674.75 General
11/22/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $48.03 General
Category: FACIAL AESTHETICS
11/22/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $40.97 General
Category: FACIAL AESTHETICS
11/22/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $39.56 General
Category: FACIAL AESTHETICS
11/21/2024 ABBVIE INC. BOTOX (Biological) Travel and Lodging In-kind items and services $445.96 General
Category: FACIAL AESTHETICS
11/21/2024 ABBVIE INC. BOTOX (Biological) Travel and Lodging In-kind items and services $336.79 General
Category: FACIAL AESTHETICS
11/21/2024 ABBVIE INC. BOTOX (Biological) Travel and Lodging In-kind items and services $326.84 General
Category: FACIAL AESTHETICS
11/21/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $59.85 General
Category: FACIAL AESTHETICS
11/21/2024 ABBVIE INC. BOTOX (Biological) Travel and Lodging In-kind items and services $58.00 General
Category: FACIAL AESTHETICS
11/21/2024 ABBVIE INC. BOTOX (Biological) Travel and Lodging In-kind items and services $24.12 General
Category: FACIAL AESTHETICS
11/20/2024 ABBVIE INC. Food and Beverage In-kind items and services $89.11 General
11/20/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $35.00 General
Category: FACIAL AESTHETICS
11/20/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $17.57 General
Category: FACIAL AESTHETICS

Research Studies & Clinical Trials

Study Name Company Amount Records
Prospective, evaluator-blind, multicenter study to assess the safety and effectiveness of treatment with the Octave System for lifting the eyebrow and improving the appearance of the face and neck MERZ NORTH AMERICA, INC. $15,000 1
Prospective, evaluator-blind, multicenter study to assess the safety and effectiveness of treatment with the Octave System for lifting the eyebrow and improving the appearance of the face and neck Merz North America, Inc. $8,475 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 554 567 $478,689 $174,344
2022 10 857 864 $506,861 $181,810
2021 12 1,362 1,386 $601,287 $219,592
2020 14 1,381 3,523 $626,075 $219,414
Total Patients
4,154
Total Services
6,340
Medicare Billing
$795,161
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
15823 Removal of excessive skin and fat of upper eyelid Facility 2023 215 215 $373,305 $138,351 37.1%
67904 Repair of tendon of upper eyelid Facility 2023 30 31 $51,011 $19,174 37.6%
67950 Reconstruction of eyelid margin Facility 2023 23 26 $27,899 $8,121 29.1%
92082 Exam of visual field with intermediate testing Office 2023 164 168 $16,464 $5,171 31.4%
92081 Exam of visual field with limited testing Office 2023 94 99 $6,930 $2,581 37.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 16 16 $2,528 $767.07 30.3%
92285 Photography of content of eyes Office 2023 12 12 $552.00 $179.90 32.6%
15823 Removal of excessive skin and fat of upper eyelid Facility 2022 179 179 $311,281 $117,708 37.8%
67904 Repair of tendon of upper eyelid Facility 2022 30 30 $53,525 $20,047 37.5%
67966 Removal of over 1/4 of eyelid margin and repair of eyelid Facility 2022 22 23 $31,901 $10,413 32.6%
67950 Reconstruction of eyelid margin Facility 2022 31 33 $33,774 $9,047 26.8%
92082 Exam of visual field with intermediate testing Office 2022 256 260 $25,480 $8,045 31.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 121 121 $19,118 $6,703 35.1%
68320 Repair of eyelid lining with graft from external eye Facility 2022 13 13 $14,755 $5,126 34.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 37 37 $8,399 $2,135 25.4%
92285 Photography of content of eyes Office 2022 150 150 $6,900 $1,947 28.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 18 18 $1,728 $639.20 37.0%
15823 Removal of excessive skin and fat of upper eyelid Facility 2021 200 200 $347,220 $133,212 38.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 268 275 $43,450 $18,283 42.1%
67904 Repair of tendon of upper eyelid Facility 2021 27 27 $47,858 $18,227 38.1%
92082 Measurement of field of vision during daylight conditions, intermediate examination Office 2021 294 295 $28,910 $9,812 33.9%
67950 Enlargement of eyelid margin Facility 2021 30 36 $36,711 $9,746 26.5%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 95 95 $21,565 $7,112 33.0%
68320 Repair of conjunctiva with graft from external eye Facility 2021 15 17 $19,862 $6,699 33.7%
67966 Removal of over one-fourth of the eyelid involving lid margin Facility 2021 15 15 $20,805 $5,800 27.9%

About Dr. John Fezza, MD

Dr. John Fezza, MD is a Ophthalmology healthcare provider based in Venice, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184715187.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Fezza, MD has received a total of $3.4M in payments from pharmaceutical and medical device companies, with $586,458 received in 2024. These payments were reported across 3,220 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.9M).

As a Medicare-enrolled provider, Fezza has provided services to 4,154 Medicare beneficiaries, totaling 6,340 services with total Medicare billing of $795,161. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Ophthalmology
  • Other Specialties Ophthalmic Plastic and Reconstructive Surgery
  • Location Venice, FL
  • Active Since 09/27/2006
  • Last Updated 11/27/2023
  • Taxonomy Code 207W00000X
  • Entity Type Individual
  • NPI Number 1184715187

Products in Payments

  • BOTOX (Biological) $1.3M
  • BOTOX COSMETIC (Biological) $75,483
  • KYBELLA (Biological) $12,173
  • Lacrifill (Device) $4,999
  • Xeomin (Biological) $3,386
  • XEOMIN (Biological) $789.31
  • Cequa (Drug) $125.00
  • TEPEZZA (Drug) $119.06
  • TYRVAYA (Drug) $81.91
  • Omidria (Drug) $38.01
  • Rhopressa (Drug) $23.72
  • Superion Indirect Decompression System (Device) $18.81
  • Flarex (Drug) $15.77

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Ophthalmology Doctors in Venice